Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Net Asset Value(s)

30 Jul 2019 10:51

Think ETF's - Net Asset Value(s)

Think ETF's - Net Asset Value(s)

PR Newswire

London, July 30

IdentifierDateNAVShares OutstandingTotal AssetsCurrency
NL000927274929-07-201957.94992,870,000166,316,213EUR
NL000927275629-07-201981.9315300,00024,579,450EUR
NL000927276429-07-201958.7172173,00010,158,076EUR
NL000927277229-07-201963.0916318,00020,063,129EUR
NL000927278029-07-201965.7847200,00013,156,940EUR
NL000969022129-07-201943.017221,246,190913,951,604EUR
NL000969023929-07-201940.95635,285,404216,470,592EUR
NL000969024729-07-201918.95281,958,39037,116,974EUR
NL000969025429-07-201914.5322,216,53732,210,716EUR
NL001027380129-07-201922.03236,321,000139,266,168EUR
NL001040870429-07-201986.52643,390,000293,324,496EUR
NL001073181629-07-201955.8915785,00043,874,828EUR
NL001137607429-07-201933.872175,2555,936,237EUR
NL001168359429-07-201928.10711,000,00028,107,100EUR
Total1,944,532,523

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.